← Open Payments lookup

SOFIA CHAGOLLAN: Open Payments

NPI 1841988086 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,735 in 81 payments from 15 companies in 2025. Trend: 2023 $917 · 2024 $2,154 · 2025 $1,735

Food & beverage: $1,735
CompanyPaymentsAmount
ABBVIE INC.31$679
Salix Pharmaceuticals, a division of Bausch Health US, LLC11$199
Janssen Biotech, Inc.7$169
Madrigal Pharmaceuticals5$110
Ardelyx, Inc.5$99
Gilead Sciences, Inc.4$79
Braintree Laboratories, Inc.3$76
Lilly USA, LLC3$69
Takeda Pharmaceuticals U.S.A., Inc.3$65
Biocon Biologics Inc2$46

Products named: SKYRIZI, LINZESS, TREMFYA, RINVOQ, CREON, XIFAXAN, REZDIFFRA, IBSRELA.

Industry payments across TX — which companies pay providers there.